Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells

Cancer Letters

Volumn 175, Issue 1, 2002, Pages 27-38

  Qin, Lan F ^a   Ng, Irene O L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Cell cycle; Cell cycle related protein; Cisplatin; Hepatoma cell

Indexed keywords

CISPLATIN; DNA FRAGMENT; FAS ANTIGEN; PROTEIN BCL X; PROTEIN P21; PROTEIN P27; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE DELETION; HEPATOMA CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ACTINS; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU NICK-END LABELING; KINETICS; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0037049879     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00720-0     Document Type: Article

References (24)

1. Activation of programmed cell death by anticancer agents: Cisplatin as a model system
2. Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes
3. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines
4. IL-12 synthesis by human Langerhans cells
5. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways
6. Pharmacokinetics of cis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions
7. Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma
8. A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancer
9. Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma
10. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma
11. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
12. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line
13. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines
14. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
15. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
16. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
17. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins
18. Inhibitors of mammalian G1 cyclin-dependent kinases
19. Growth suppression by p16ink4 requires functional retinoblastoma protein
20. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
21. Double identity for proteins of the Bcl-2 family
22. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer
23. Bcl-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells
24. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells